PL3949949T3 - Kompozycja do iniekcji podśluzówkowej - Google Patents

Kompozycja do iniekcji podśluzówkowej

Info

Publication number
PL3949949T3
PL3949949T3 PL21158949.4T PL21158949T PL3949949T3 PL 3949949 T3 PL3949949 T3 PL 3949949T3 PL 21158949 T PL21158949 T PL 21158949T PL 3949949 T3 PL3949949 T3 PL 3949949T3
Authority
PL
Poland
Prior art keywords
composition
submucosal injection
submucosal
injection
Prior art date
Application number
PL21158949.4T
Other languages
English (en)
Inventor
Chih-Chiang Lin
Chun-Yao Huang
Hung-En WEI
Hui-fang Li
Original Assignee
T-ACE Medical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T-ACE Medical Co., Ltd. filed Critical T-ACE Medical Co., Ltd.
Publication of PL3949949T3 publication Critical patent/PL3949949T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0033—Xanthan, i.e. D-glucose, D-mannose and D-glucuronic acid units, saubstituted with acetate and pyruvate, with a main chain of (beta-1,4)-D-glucose units; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0096—Guar, guar gum, guar flour, guaran, i.e. (beta-1,4) linked D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from Cyamopsis Tetragonolobus; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
PL21158949.4T 2020-08-06 2021-02-24 Kompozycja do iniekcji podśluzówkowej PL3949949T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063061810P 2020-08-06 2020-08-06

Publications (1)

Publication Number Publication Date
PL3949949T3 true PL3949949T3 (pl) 2024-04-08

Family

ID=74732747

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21158949.4T PL3949949T3 (pl) 2020-08-06 2021-02-24 Kompozycja do iniekcji podśluzówkowej

Country Status (6)

Country Link
US (1) US11679076B2 (pl)
EP (1) EP3949949B1 (pl)
CN (1) CN114286673A (pl)
PL (1) PL3949949T3 (pl)
TW (1) TWI849288B (pl)
WO (1) WO2022027970A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000012173A (ko) * 1999-03-26 2000-03-06 김공수 저분자다당류및올리고당의제조방법
JPWO2013077357A1 (ja) * 2011-11-25 2015-04-27 日本製薬株式会社 粘膜下膨隆剤
CN106456789A (zh) * 2013-10-07 2017-02-22 波士顿科学国际有限公司 可注射组合物
US10179190B2 (en) * 2015-05-29 2019-01-15 Boston Scientific Scimed, Inc. Compositions and methods for treatment of tissue
WO2018017861A1 (en) * 2016-07-21 2018-01-25 Boston Scientific Scimed, Inc. Injectable compositions
AU2017329872A1 (en) * 2016-09-21 2019-04-11 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent zinc cation
TWI640328B (zh) * 2017-01-09 2018-11-11 國立成功大學 可供內視鏡治療術應用的即溶乾燥粉末
KR101884467B1 (ko) * 2017-06-12 2018-08-02 한국맥널티 주식회사 알긴산 또는 그 약학적으로 허용되는 염과 콜로이드성 다당류를 함유하는 액상 조성물
EP3689333A4 (en) * 2017-09-25 2021-07-14 Kyoto Prefectural Public University Corporation LOCAL INJECTION SOLUTION WITH TWO MEDICINAL PRODUCTS FOR SUBMUCOSAL INJECTION
EP3821920A4 (en) * 2018-07-13 2022-03-02 T-ACE Medical Co., Ltd. SUIT FOR ENDOSCOPIC SURGERY

Also Published As

Publication number Publication date
EP3949949B1 (en) 2023-11-08
CN114286673A (zh) 2022-04-05
US11679076B2 (en) 2023-06-20
WO2022027970A1 (zh) 2022-02-10
TW202206107A (zh) 2022-02-16
EP3949949A1 (en) 2022-02-09
US20220040091A1 (en) 2022-02-10
TWI849288B (zh) 2024-07-21

Similar Documents

Publication Publication Date Title
IL290544A (en) Methods of manufacturing improved arganoid preparations
EP4256011C0 (en) COMPOSITION
GB202115101D0 (en) Composition
EP3648739B8 (en) Composition for injection
GB202004460D0 (en) Herbical composition
GB202018029D0 (en) Composition
GB202012895D0 (en) Composition
GB202117602D0 (en) Solid composition
PT4161717T (pt) Aglutinante para composição de moldagem por injeção
GB202105455D0 (en) Composition
GB202016236D0 (en) Composition
PL3949949T3 (pl) Kompozycja do iniekcji podśluzówkowej
GB202104138D0 (en) Additive composition
GB202111898D0 (en) Composition
GB202104498D0 (en) Composition
GB202014635D0 (en) Composition
GB202003550D0 (en) Composition
GB202108946D0 (en) Additive composition
GB202013513D0 (en) Additive composition
GB202116513D0 (en) Composition
GB202116333D0 (en) Composition
GB202114743D0 (en) Composition
GB202114789D0 (en) Composition
GB202114569D0 (en) Composition
EP4176034C0 (en) COMPOSITION